UNH is one of the most vertically integrated healthcare stocks, being both the US's largest insurer, and the owner of one of the big 3 PBMs, which is part of its OptumRx business. It's clear that ...

Earlier this week, President Trump said that pharmacy benefit managers, or PBMs, would be left out of a new government initiative aimed at bringing down the cost of prescription drugs for ...

and OptumRx. According to World Population Review, insulin in the U.S. is $98.70, much more than in other countries. "Insulin costs five times what it does in Chile, six times what it does in ...

I'm surprised to see all the negative reviews of this company as I've had good service from them. Perhaps it's because I've had no change in provider, haven't taken the auto-renew option, and my ...

CVS Health subsidiary CVS Caremark, Cigna's Express Scripts and UnitedHealth Group's OptumRx collectively hold 70% of the PBM market, according to the American Medical Association. And attorneys ...

In the background, FOX 9 has reported extensively on FTC's review of pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx. A report accused the PBMs of inflating drug prices ...

and UnitedHealth's OptumRx. It concludes that the PBMs generated $7.3 billion by marking up drugs in these categories over their estimated acquisition costs between 2017 and 2022, in some cases by ...

Some PBMs not cooperating with the investigation The FTC started its probe into the sector in 2022, asking the top six players in the market – CVS Caremark, Express Scripts, OptumRx, Humana ...

In the background, FOX 9 has reported extensively on FTC's review of pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx. A report accused the PBMs of inflating drug prices, with some ...

Pharmacy benefit managers CVS Caremark, Express Scripts, and OptumRx are listed as defendants, as are insulin manufacturers Eli Lilly and Company, Novo Nordisk, and Sanofi. Fitzpatrick announced the ...